FR2368474B1 - Lactames n-substitues et compositions pharmaceutiques en renfermant - Google Patents

Lactames n-substitues et compositions pharmaceutiques en renfermant

Info

Publication number
FR2368474B1
FR2368474B1 FR7731876A FR7731876A FR2368474B1 FR 2368474 B1 FR2368474 B1 FR 2368474B1 FR 7731876 A FR7731876 A FR 7731876A FR 7731876 A FR7731876 A FR 7731876A FR 2368474 B1 FR2368474 B1 FR 2368474B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions containing
containing same
substituted lactams
lactams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7731876A
Other languages
English (en)
Other versions
FR2368474A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB SA filed Critical UCB SA
Publication of FR2368474A1 publication Critical patent/FR2368474A1/fr
Application granted granted Critical
Publication of FR2368474B1 publication Critical patent/FR2368474B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7731876A 1976-10-22 1977-10-19 Lactames n-substitues et compositions pharmaceutiques en renfermant Expired FR2368474B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (2)

Publication Number Publication Date
FR2368474A1 FR2368474A1 (fr) 1978-05-19
FR2368474B1 true FR2368474B1 (fr) 1980-08-08

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7731876A Expired FR2368474B1 (fr) 1976-10-22 1977-10-19 Lactames n-substitues et compositions pharmaceutiques en renfermant

Country Status (27)

Country Link
US (1) US4162325A (fr)
JP (1) JPS5839148B2 (fr)
AT (1) AT352742B (fr)
BE (1) BE859925A (fr)
BG (1) BG28413A3 (fr)
CA (1) CA1095040A (fr)
CH (1) CH625214A5 (fr)
CS (1) CS200231B2 (fr)
CY (1) CY1037A (fr)
DD (1) DD131930A5 (fr)
DE (1) DE2747369A1 (fr)
DK (1) DK461877A (fr)
ES (1) ES463424A1 (fr)
FI (1) FI66600C (fr)
FR (1) FR2368474B1 (fr)
GB (1) GB1539817A (fr)
HK (1) HK2380A (fr)
HU (1) HU174864B (fr)
IL (1) IL53171A (fr)
KE (1) KE3013A (fr)
MY (1) MY8000264A (fr)
NL (1) NL7711414A (fr)
PL (1) PL110679B1 (fr)
SE (1) SE425782B (fr)
SU (2) SU805945A3 (fr)
YU (1) YU251977A (fr)
ZA (1) ZA776260B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960194D1 (en) * 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
EP0115473A3 (fr) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Dérivés substitués de pyrrolidinone et leur procédé de préparation
EP0115472A3 (fr) * 1983-01-27 1985-10-02 Ciba-Geigy Ag Dérivés de la pyrrolidinone et leur procédé de préparation
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0419683A4 (en) * 1989-04-13 1992-03-11 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
ZA776260B (en) 1978-07-26
GB1539817A (en) 1979-02-07
SU937450A1 (ru) 1982-06-23
DE2747369A1 (de) 1978-04-27
PL110679B1 (en) 1980-07-31
HU174864B (hu) 1980-03-28
FR2368474A1 (fr) 1978-05-19
BG28413A3 (en) 1980-04-15
IL53171A0 (en) 1977-12-30
US4162325A (en) 1979-07-24
YU251977A (en) 1983-01-21
DD131930A5 (de) 1978-08-09
AT352742B (de) 1979-10-10
JPS5353649A (en) 1978-05-16
PL201601A1 (pl) 1979-01-29
CY1037A (en) 1980-08-01
ES463424A1 (es) 1978-07-16
FI66600C (fi) 1984-11-12
CH625214A5 (fr) 1981-09-15
BE859925A (fr) 1978-04-20
DK461877A (da) 1978-04-23
ATA749677A (de) 1979-03-15
NL7711414A (nl) 1978-04-25
IL53171A (en) 1982-02-28
MY8000264A (en) 1980-12-31
DE2747369C2 (fr) 1987-11-12
JPS5839148B2 (ja) 1983-08-27
FI773069A (fi) 1978-04-23
FI66600B (fi) 1984-07-31
CS200231B2 (en) 1980-08-29
SU805945A3 (ru) 1981-02-15
HK2380A (en) 1980-01-25
CA1095040A (fr) 1981-02-03
SE425782B (sv) 1982-11-08
SE7711667L (sv) 1978-04-23
KE3013A (en) 1980-02-01

Similar Documents

Publication Publication Date Title
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
IL49204A0 (en) N-(4-piperidinyl)-n-phenylamides and-carbamates,their preparation and pharmaceutical compositions containing them
JPS54109963A (en) Amine derivatives* their manufacture and pharmaceutical composition containing them
BE851590A (fr) Compositions pharmaceutiques renfermant des pyrethrinoides
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ185986A (en) 2-oxa-bicyclic prostag-landins and pharmaceutical compositions
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ185358A (en) Spiro-hydantoins and pharmaceutical compositions
FR2316943A1 (fr) Pyrrolidones et medicaments qui en contiennent
JPS5386038A (en) Pharmaceutical composition for animal and application
NZ184428A (en) N-acyl-l-alanyl-aminoacyl-amides untermediates and pharmaceutical compositions
FR2368474B1 (fr) Lactames n-substitues et compositions pharmaceutiques en renfermant
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
IL52433A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine and pharmaceutical compositions containing them
NZ184263A (en) N-(amino-alkyl-amino)-benzamides and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ184912A (en) 2-phenylamino-imidazolines and pharmaceutical compositions
IL52409A0 (en) 5-m-tolyloxyuracil and pharmaceutical compositions containing it
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof
NZ184808A (en) Heterocyclic compounds and pharmaceutical compositions
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
BE849346R (fr) Pyrrolidones et medicaments qui en contiennent
AU506783B2 (en) Cyclic amides and pharmaceutical compositions containing them
FR2316941A1 (fr) Pyrrolidones et medicaments qui en contiennent

Legal Events

Date Code Title Description
ST Notification of lapse